Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

BioReference Laboratories nabs Edge Biosystemsí CLIA lab business
October 2013
SHARING OPTIONS:

ELMWOOD PARK, N.J.óBioReference Laboratories Inc. (BRLI) has signed a definitive agreement to acquire Edge BioSystems' CLIA laboratory business and related assets (Edge BioServ). GeneDx, BRLI's wholly owned clinical diagnostic sequencing laboratory, will acquire the Edge BioServ genetic sequencing services business. No financial details were disclosed. Dean Gaalaas, CEO of EdgeBio, will take over as chief operating officer at GeneDx.  
 
"Our GeneDx genetics laboratory is growing rapidly in a very sophisticated and complex area of laboratory medicine, and we believe the Edge BioServ acquisition will enable us to have instant expandability for that growth. We believe that our existing genetics capabilities have made GeneDx a superior genetics sequencing laboratory, and we expect the Edge BioServ acquisition will provide depth and capability to further enhance our premier status," said Dr. Marc D. Grodman, CEO of BRLI.  
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.